Meanwhile, virus-negative tumors had higher odds of TP53 mutations (OR = 8.20, 95% CI = 4.79–8.20, q = 4.60e-52), which were significant and known for most cancer types individually, including HNSCC2, GC105, MCC18, BL21, PBL120, among others. Here, TP53 is linked to cancer.